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Abstract
Background:  Survival in colorectal cancer may correlate with the degree of systemic
inflammatory response to the tumour. Atrial fibrillation may be regarded as an inflammatory
complication. We aimed to determine if atrial fibrillation is a prognostic factor in colorectal cancer.
Patients and methods: A prospective colorectal cancer patient database was cross-referenced
with the hospital clinical-coding database to identify patients who had underwent colorectal cancer
surgery and were in atrial fibrillation pre- or postoperatively.
Results: A total of 175 patients underwent surgery for colorectal cancer over a two-year period.
Of these, 13 patients had atrial fibrillation pre- or postoperatively. Atrial fibrillation correlated with
worse two-year survival (p = 0.04; log-rank test). However, in a Cox regression analysis, atrial
fibrillation was not significantly associated with survival.
Conclusion: The presence or development of atrial fibrillation in patients undergoing surgery for
colorectal cancer is associated with worse overall survival, however it was not found to be an
independent factor in multivariate analysis.
Background
In general, colorectal cancer patients are three times more
likely to be in atrial fibrillation preoperatively than
matched controls undergoing non-colorectal cancer sur-
gery [1,2]. It may also occur postoperatively. Recent data
suggest that atrial fibrillation may be an inflammatory
complication, resulting from the initiation of an inflam-
matory response to surgery or infection [3-6]. Colorectal
cancer patients may have elevated C-reactive protein
(CRP) levels [7] indicating a systemic inflammatory
response. Elevated CRP levels may be associated with a
worse prognosis in colorectal cancer patients [8]. Postop-
erative dysrhythmias may [9] or may not [10] be associ-
ated with worse survival following surgery for lung cancer.
We hypothesised that atrial fibrillation (AF) is an adverse
prognostic indicator in patients undergoing surgery for
colorectal cancer.
Patients and methods
Patients who underwent a resection for colorectal cancer
between 1st January 2000 and 31st December 2001 in a
600-bed district general hospital in the United Kingdom
National Health Service were identified. The hospital
serves a population of approximately 230,000. About 90
elective and emergency laparotomies are performed each
year for colorectal cancer. Patients were identified from
Published: 29 November 2004
World Journal of Surgical Oncology 2004, 2:40 doi:10.1186/1477-7819-2-40
Received: 31 August 2004
Accepted: 29 November 2004
This article is available from: http://www.wjso.com/content/2/1/40
© 2004 Walsh et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.World Journal of Surgical Oncology 2004, 2:40 http://www.wjso.com/content/2/1/40
Page 2 of 5
(page number not for citation purposes)
the prospectively maintained colorectal cancer database
maintained by the colorectal surgical department.
Patients with radiological, endoscopic or clinical exami-
nations suspicious of colorectal cancer are referred to the
weekly colorectal multi-disciplinary team (MDT) meet-
ing. In the case of suspicious radiology, the referral to the
MDT is made automatically by the radiology department.
This avoids the possibility of the responsible clinical firm
failing to refer a patient for consideration. Similarly, the
pathology department automatically refers any patient in
whom histology shows colorectal malignancy. In addi-
tion, patients who undergo surgery where a suspicion of
colorectal cancer is raised are referred for consideration.
The colorectal meeting is attended by the colorectal sur-
geons, radiologists, pathologists, palliative care physi-
cians and nursing staff. Patients determined to have
colorectal cancer by the MDT are entered into the data-
base. The colorectal department periodically compares
the database to clinical coding data for patients with
colorectal cancer in order to ensure complete data capture.
All patients are followed-up regularly by a team of color-
ectal nurse specialists in a dedicated clinic.
Age, sex, mode of presentation (emergency or elective),
Dukes stage, postoperative anastomotic leakage and adju-
vant therapy were recorded for all patients. The colorectal
cancer database was cross-referenced with the hospital
clinical-coding database to identify those patients who
were in atrial fibrillation at any time before or after their
surgery. Patients with colorectal cancer who did not
undergo surgery or who only underwent palliative stoma
formation were excluded. All patients were followed up
for at least two years postoperatively. Overall survival and
recurrence-free survival were recorded. Recurrence-free
survival was defined as the time interval between opera-
tion and first diagnosis of local or distant recurrence.
Patients with no recurrence were censored at the time of
death from any cause other than cancer or at the time they
were last seen by the colorectal team. Characteristics
between those with and without AF were compared using
the Student t-test and Fisher Exact test for continuous and
categorical data respectively. Potential prognostic factors
were compared by the log-rank test. Significant prognostic
factors identified from the univariate analysis were
entered into a multivariate Cox regression model of sur-
vival to test for independence. The 5% level was consid-
ered significant in the multivariate analysis. Statistical
analysis was performed using Statsdirect® version 2 (Stats-
direct Ltd., UK).
Results
One hundred and seventy-five patients (M:F = 111:64)
who underwent bowel resection for colorectal cancer were
identified from the database. Their median age was 74
years (interquartile range 66 to 80 years). Tumour site,
Dukes stage and mode of operation (emergency or elec-
tive) are summarised in Table 1. Anastomotic leaks
occurred in three patients while another three patients
received preoperative radiotherapy. Median follow-up
was 2.38 years. There were 60 deaths (42 cancer-specific
deaths) during the follow-up period. The remaining 18
patients died from conditions such as pneumonia, pul-
monary embolus or myocardial infarction. Cause of death
was recorded for all patients in the database. Twenty-eight
patients (16%) developed recurrence during postopera-
tive surveillance. The remaining 14 patients who died
were noted to have incurable disease at the time of
surgery.
Cross-referencing with the clinical coding database identi-
fied thirteen patients with a history of atrial fibrillation.
Five patients were in AF preoperatively. The remaining
eight patients developed postoperative AF. A comparison
of baseline characteristics between patients with and
Table 2: Comparison of characteristics between patients with AF and those without.
Characteristic Sinus rhythm Atrial fibrillation p
Male gender 102 9 0.77
Mean age 72 73 0.64
Rectal cancer 52 4 0.99
Elective surgery 139 8 0.05
Pre-operative radiotherapy 2 1 0.22
Anastomotic leak 3 0 0.79
Dukes Stage
A2 4 2 0 . 7 3 *
B6 9 6
C5 3 4
D1 6 1
*Fisher-Freeman-Halton Exact TestWorld Journal of Surgical Oncology 2004, 2:40 http://www.wjso.com/content/2/1/40
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without AF is shown in table 2. The AF was paroxysmal in
three patients, persistent but eventually resolved in five
and permanent in the remaining five patients. There were
seven deaths among the patients with atrial fibrillation:
two from recurrent colorectal cancer, four from other
causes (pneumonia in two patients, respiratory failure sec-
ondary to pulmonary fibrosis in one and left ventricular
failure in one) with recurrent cancer present and one non-
cancer related death (peri-operative myocardial
infarction).
Survival analysis
There was no correlation between overall survival and the
following variables in the univariate survival analysis:
gender, postoperative anastomotic leak, site of tumour
(rectal versus colonic) or preoperative radiotherapy.
Mode of surgery (emergency or elective), age (<72 years or
≥ 72 years) and Dukes' stage had a significant effect on
survival. When patients with atrial fibrillation were com-
pared to those without (Figure 1), atrial fibrillation corre-
lated with worse overall survival. Dukes' stage, mode of
surgery, age and atrial fibrillation were entered into a Cox
regression model overall survival (Table 2). Mode of sur-
gery, age and Dukes' stage retained significance but atrial
fibrillation did not (Model chi-square 49.6; 7 degrees of
freedom; p < 0.0001). There was no significant correlation
between atrial fibrillation and recurrence-free survival (p
= 0.74).
Discussion
Tumours stimulate an inflammatory response when they
invade or metastasise [11]. This inflammation may cause
a rise in serum levels of inflammatory markers such as
CRP. Serum CRP levels correlate with survival in colorec-
tal cancer patients [8]. Atrial fibrillation may be precipi-
tated or maintained by an inflammatory mechanism [3].
Thus, we hypothesised that the presence of AF, an inflam-
matory complication, would be associated with poorer
survival in colorectal cancer as it is a manifestation of
more advanced disease. Our data demonstrate a signifi-
cant correlation between atrial fibrillation and survival
following surgery for colorectal cancer in univariate anal-
ysis. Previous investigators have found that atrial arrhyth-
mias were significantly more common in those patients
with a history of cancer. In addition, CRP levels were
higher in those patients with a history of cancer. However,
there was no independent link between cancer and
arrhythmias. This is consistent with inflammation being
the causal link between cancer and arrhythmias [12].
In our cohort, atrial fibrillation was not an independent
predictor of survival. Dukes' stage was the strongest pre-
dictor of survival. Previous data from colorectal cancer
patients suggest the degree of inflammatory response may
reflect the degree of disease progression [13]. The inci-
dence of liver metastases, peritoneal tumour deposits,
lymph node metastases and intravascular invasion are
higher in patients with elevated CRP levels [14]. Thus,
atrial fibrillation may be a manifestation of systemic
inflammation due to more advanced disease and would
not be independent of Dukes' stage. Cox regression anal-
ysis of our study cohort (Table 3) appears to show poor
survival in Dukes B patients (Hazard ratio 9.13)
compared to Dukes C patients (Hazard ratio 0.15). There
Table 1: Baseline characteristics of study group
No. of patients (%)
Age
≥72 years 98 (56%)
< 72 years 77 (44%)
Gender
Male 111 (64%)
Female 64 (36%)
Site
Colon 119 (68%)
Rectum 56 (32%)
Dukes' Stage
A 26 (15%)
B 75 (43%)
C 57 (33%)
D1 7  ( 9 % )
Presentation
Elective 147 (84%)
Emergency 28 (16%)
Kaplan-Meier survival curves for patients with a history of  atrial fibrillation (1) versus those without (0) Figure 1
Kaplan-Meier survival curves for patients with a history of 
atrial fibrillation (1) versus those without (0). P = 0.04 (Log-
rank test).World Journal of Surgical Oncology 2004, 2:40 http://www.wjso.com/content/2/1/40
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was a trend for Dukes B patients to be older (mean age
73.79 years) than Dukes C patients (70.99 years; p = 0.1,
student t-test, β = 0.67) and this may account for the
reduced survival. There were no differences in the Dukes'
stage distribution between patients with and without AF
(Table 2). However, the small numbers in our series (only
thirteen patients with AF) render it underpowered to
detect a correlation between the presence of AF and color-
ectal cancer stage.
There are several other limitations to our study. The qual-
ity of the clinical coding has not been assessed. Thus, the
sensitivity and specificity of our clinical coding depart-
ment in coding AF is unknown. Only 13 patients (7.4%)
developed AF. Previous work suggests that 13% of elective
colorectal patients develop postoperative AF [15]. Thus, it
is possible that some patients with unrecorded AF have
been incorporated into the control arm of our series. The
study cohort has been followed for a relatively short time,
only two years. However, most trials of follow-up follow-
ing surgery for colorectal cancer report a mean time to
relapse of approximately 24 months [16]. We were unable
to demonstrate a significant relationship between atrial
fibrillation and recurrence-free survival. This may be due
to an insufficient sample size. However, atrial fibrillation
does correlate with overall survival. The presence of atrial
fibrillation may be a clinical marker of poor overall sur-
vival in patients undergoing surgery for colorectal cancer.
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